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Background: Serum albumin is a marker of nutrition and inflammation. It has recently emerged as a predictor of
outcome after surgery for rectal cancer. Our aim was to evaluate if pre-operative serum albumin would predict
survival after resection for rectal cancer.
Method: 226 Patients with rectal cancer of all stages undergoing resection with curative intent were studied.
Kaplan-Meier curves analysed survival based on a pre-operative albumin level of <35 g/L vs. >35 g/L. We sought for
significant associations of survival with age, sex, stage, tumour site, use of neoadjuvant chemoradiation, microscopic
positive resection margins, differentiation, angio, peri-neural, and lymphovascular invasion using individual variable
analysis. Multifactorial analysis was performed using type III analysis with Weibull hazard model and Cox-proportional
hazard model. Significance was assigned to a P value <0.05.
Results: Of 226 patients (median age- 59 years; range 19 – 88, Male - 54%), forty five (20%) had an albumin level < 35 g/L
and was associated with a poor overall survival (P = 0.02). Mean survival in months for <35 g/L vs. >35 g/L was 64.7
(SE - 9.3) vs. 95.8 (SE – 7.0) and 5 year overall survival rates were 49% and 69%. Individual variable analysis revealed age,
circumferential margin, stage, perineural, lympho-vascular and angio invasion to be also significant. With multifactorial
analysis hypoalbuminaemia (HR = 0.58; 95% CI: 0.35 - 0.95, P = 0.03), advanced stage (HR = 2.0; 95% CI: 1.26 - 3.23,
P < 0.01) and positive circumferential margin (HR = 2.2; 95% CI: 1.26 - 3.89, P < 0.01) remained significant.
Conclusion: Preoperative hypoalbuminaemia is an independent risk factor for poor overall survival in rectal cancer.
Advanced tumour stage and circumferential margin positivity were the other associations with poor survival.Background
Traditionally, serum albumin has been considered a
marker of nutritional status [1,2]. In this regard, several
studies have questioned its reliability as serum albumin
concentration is affected by pro-inflammatory cytokines,
stress hormone, metabolic rate, dehydration, hepatic and
renal failure [3-5]. Currently, hypoalbuminaemia is used
as a marker of inflammation, a predictor of outcome in
post-surgical patients, and is associated with increased
morbidity and mortality in patients having surgery for
malignant disease [6,7]. The Glasgow Prognostic Score
(GPS), which predicts outcome following surgery for
colorectal cancer, also considers serum albumin level as* Correspondence: pramodh@sltnet.lk
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distribution, and reproduction in any mediuman inflammatory marker rather than an indicator of nu-
trition [8]. Roxburgh et al. has reviewed the association
between the systemic inflammatory response and sur-
vival in patients with cancer where hypoalbuminaemia
was also recognised as a marker of inflammation [9].
Low serum albumin levels are known to contribute to
post-operative complications such as anastomotic leak-
age, abdominal wound dehiscence and infection [10]. Al-
though studies have established its predictive value in
surgery for colon cancer [11,12], there is lack of such
evidence in surgery for rectal cancer [13]. Evidence is
emerging with regard to the significance of inflammatory
response on survival in rectal cancer [14]. The aim of
this study was to study the effect of preoperative serum
albumin on survival following surgery for rectal cancer.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Comparison of survival using Kaplan-Meier
method based on serially ascending values of serum
albumin
Serum albumin level 5 year survival rates P value
<20 g/LVS. ≥20 g/L 90% VS. 60% 0.44
<25 g/LVS. ≥2 g/L 90% VS. 59% 0.10
<30 g/LVS. ≥30 g/L 43% VS. 63% 0.04*
<35 g/LVS. ≥35 g/L 49% VS. 69% 0.02*
<40 g/LVS. ≥40 g/L 58% VS. 62% 0.48
<45 g/LVS. ≥45 g/L 58% VS. 73% 0.17
* - significant value.
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Two hundred and twenty six patients with rectal cancer,
proven histologically, who had potentially curative re-
section at the university surgical unit between 1996 and
2010 were studied - patients with evidence of liver or
kidney failure were excluded. Rectal cancer was defined
as cancer within 12 cm from the anal verge – cancer
from 0 to 6 cm was defined as distal rectal cancer. Pre-
operative work up and management was standardized by
protocol, and described in a previous publication [15].
Surgery was performed by the same team according to
standard protocol and histological analysis of specimens
was by a single pathologist. Data collection was pro-
forma based in a continually updated prospective data-
base, where, the pre-operative serum albumin level was
entered in all patients. Post operative surveillance was
carried out with clinical examination coupled with
carcino-embryonic antigen (CEA) levels three monthly
for the first 2 years and biannually for 3 years. A colon-
oscopy and computer tomographic evaluation of the ab-
domen and pelvis at 1, 3 and 5 years post operative wasFigure 1 Overall survival comparison based on preoperative serum aunder taken. Study was approved by the ethics review
committee at the University of Kelaniya medical school,
Sri Lanka. Hypoalbuminaemia was defined as serum
albumin level less than 35 g/L. Based on this value we
defined two groups; pre-operative serum albumin less
than 35 g/L and greater than 35 g/L. Furthermore,
serially ascending values of serum albumin, in incre-
ments of 5 g/L, were analyzed to define a finite cut-off
value. We compared overall survival, disease free sur-
vival at 5 years, thirty day mortality and post operative
complications in the two groups. Initially, univariable
analysis was performed to identify factors which affected
survival; age, gender, site of the tumor (proximal rectum
vs. distal rectum), pre-operative chaemoradiation, tu-
mour stage, histological differentiation, circumferential
and distal margin clearance, peri-neural, angio-invasion,
and lymphovascular invasion. Post operative complica-
tions considered were wound infection, wound dehis-
cence and anastomotic leakage. Anastomotic leakage
was diagnosed with clinical evidence of intra abdominal
sepsis and ultrasound or CT evidence of intra peritoneal
fluid. Cancers were staged according to the American
Joint Committee on Cancer (AJCC) TNM classification.
Microscopic tumour clearance of > 1 mm for circumferen-
tial margins was considered safe (R0). Distal margin clea-
rance of >10mm for distal rectal cancers and > 50 mm for
proximal cancers was considered as R0.
Data are expressed as median and range. A two sample
test of proportions with a 95% confidence interval test was
used to compare thirty day mortality and complication
rates of those with serum albumin less than 35 g/L versus
greater than 35 g/L. Survival analysis was performed using
Kaplan Meier curves. Univariable analysis was performed
using Kaplan-Meier analysis and Cox proportional hazardlbumin level using Kaplan-Meier method.
Table 2 Individual variable analysis for recognized
determinants of survival for rectal cancer using Kaplan-




< 35 g/L n = 45(%)
Albumin






Age Continuos variable Continuos variable 0.05
Site (Low < 6 cm) 0.79
Upper 27 (60%) 94 (52%)
Lower 18 (40%) 87 (48%)
Neoadjuvant CRT 0.90
Given 08 (18%) 68 (38%)
Not given 37 (82%) 113 (62%)
Tumour stage 0.002*
AJCC+ 27 (60%) 91 (50%)
AJCC III/IV 18 (40%) 90 (50%)
Differentiation 0.18
Well 04 (9%) 26 (15%)
Moderate 37 (82%) 133 (73%)




R0 35 (78%) 156 (86%)
R1 10 (22%) 25 (14%)
Distal margin 0.07
R0 40 (89%) 163 (90%)
R1 05 (11%) 18 (10%)
Peri-neural invasion 07 (16%) 18 (10%) <0.001*
Angio invasion 05 (11%) 14 (8%) <0.001*
Lympho-vascular
invasion
08 (18%) 15 (8%) <0.001*
+ American joint committee on cancer.
*Significant values.
Table 3 Two-way interaction terms for significant factors
affecting survival using multifactorial analysis with a
Weibull hazard model
Factors DF Chi squared P value
Circumferential margin positivity 1 5.7647 0.01*
Serum albumin level 1 6.1745 0.01*
Circumferential margin positivity ×
serum albumin
1 0.9343 0.33
AJCC stage 1 7.8196 0.005*
Circumferential margin positivity ×
AJCC stage
1 1.6852 0.19
AJCC stage × serum albumin level 1 0.5503 0.45
× Interaction between two factors.
*Significant values.
Table 4 Hazard ratios calculated for significant
determinants of survival using Cox-proportional hazard
model
Factor DF PE Hazard ratio 95% CI P value
Circumferential
margin positvity
1 0.79 2.22 1.26 - 3.89 0.005
Albumin level 1 -0.53 0.58 0.35 - 0.95 0.032
AJCC stage III/IV 1 0.70 2.02 1.26 - 3.23 0.003
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significant factors that affected survival by a type III ana-
lysis with a Weibull hazard model and two-way inter-
action terms. Hazard ratios (HR) for significant factors,
identified through type III analysis, were computed using
a Cox proportional hazard model. A P- value of less than
0.05 was regarded as significant. Statistical analysis
was performed with the SAS/STAT statistical software
(SAS system, version 9.0; SAS Institute, Cary, North
Carolina).
Results
123 (54%) Male and 103 female patients were studied.
The median age of the population (n = 226) was 59 years(range 19 – 88 years). Median follow up was 36 months
(range 10 – 160). Forty five patients (20%) had hypoal-
buminaemia (serum albumin less than 3.5 g/L). We found
that a serum albumin level of 35 g/L was the cut-off value
at which most significant differences in survival emerged
(Table 1). Overall survival following surgery for rectal can-
cer became significantly poor in patients having preopera-
tive serum albumin less than 35 g/L compared with those
with a serum albumin greater than 35 g/L (P = 0.02;
Figure 1). Overall five year survival rates were 47% and
69% for the two groups respectively. The five year disease
free survival rate in the hypoalbuminaemic group was
69.7% compared to 83% in those with a serum albumin
above 35g/L (P = 0.02). Other factors which influenced
survival significantly, using univariable analysis, were age,
positive circumferential margin, peri-neural invasion,
angio-invasion, lympho-vascular invasion, and advanced
AJCC stage (Table 2). Multi factorial model type III
analysis of effects revealed that hypo-albuminaemia
(P = 0.002), a positive circumferential margin (P = 0.002),
and AJCC stages III and IV compared with I and II
(P = 0.003), were significant. However, when two-way inter-
action terms were added, using Weibull analysis, none was
found to be significant (Table 3). Therefore hypoalbu-
minaemia, a positive circumferential margin, and advanced
AJCC stage (III and IV) were identified as independent
risk factors for poor survival following surgery for rectal
cancer.
Chandrasinghe et al. BMC Clinical Pathology 2013, 13:12 Page 4 of 5
http://www.biomedcentral.com/1472-6890/13/12Hazard ratios calculated using Cox proportional hazard
model showed albumin level above 35 g/L to have a ha-
zard of 0.58 ; 95% CI: 0.35 - 0.95; P = 0.03 (Table 4). Thirty
day mortality rate in the hypo-albuminaemic group was
2% compared to 1% in the normo-albuminaemic group
( 95% CI: -3.4 - 5.4 ; P = 0.65). Post operative complication
rates between the two groups were also not significantly
different (albumin < 35 g/L - 22.9% vs. albumin > 35 g/L -
12.3%; 95% CI: - 2.2 - 23.3; P = 0.17).
Discussion
The current study shows a significant association be-
tween a low preoperative serum albumin of less than
35 g/ L, with a reduction in overall survival for patients
undergoing surgery for rectal cancer. Heys et al., in the
earliest available study of 481 patients with colon and
rectal cancer, demonstrated a significant association bet-
ween preoperative serum albumin and survival in large
bowel cancer [16]. Since current evidence supports the
observation that colon cancer is different to rectal can-
cer in terms of biological and clinicopathological charac-
teristics [17,18] the authors feel that the two are best
studied separately. A recent study on preoperative hypo-
albuminemia in rectal cancer demonstrated its’ signi-
ficant association with poor short term outcome only
[13]. Lohsiriwat et al. in this study demonstrated a
higher rate of overall postoperative complications and a
longer hospital stay associated with hypoalbuminaemia,
but did not report on overall survival. The current study
did not show a statistical significant difference in the
thirty day mortality and postoperative complication rate
although both statistics were halved in the group with a
serum albumin level of greater than 35 g/L. Taking colon
cancer into consideration, some studies which reported
predictability of survival using pre-operative albumin
levels in serum, reported variable cut off values of albu-
min as a predictor of survival [18,19]. These studies have
serum albumin level as a continuous variable. In the
current study the highest significance with regard to
overall survival was observed at an albumin level of
35 g/L when survival was compared with a univariable
analysis based on serially ascending values of serum
albumin. This corresponds to the lower limit of the stan-
dard range, reported in laboratories [20]. Roxburgh et al.
in a review looking in to role of the systemic inflamma-
tory response (SIR) in predicting survival for patients
with cancer using biochemical or haematological mar-
kers recognised hypoalbuminaemia to be significant as
an inflammatory marker along with C-reactive protein
(CRP), neutrophils and lymphocyte/ platelet ratio [9]. A
recent study by Carruthers et al. on patients with locally
advanced rectal cancer concluded that the SIR is a pre-
dictor of overall and disease free survival outcome inthose receiving neoadjuvant chemoradiation [14]. The
authors have used neutrophil/ lymphocyte ratio as the
indicator of inflammation. McMillan et al. in 2007 pro-
posing the modified GPS reported a higher survival pre-
dictive value in CRP compared to hypoalbuminaemia in
patients with Dukes stage B and C colorectal cancers
[21]. Same group in a recent study assessing the out-
come of the modified GPS in a lager cohort (n = 8759)
reported that 90% of cancer patients with a low albumin
level had an elevated CRP [22]. Therefore in a setting
where serum albumin is assessed with routine liver pro-
file, it appears to be a both cost effective and a sensitive
marker to predict outcome given the fact that in a large
majority the two markers correlate.
In the current study both overall survival and disease
free survival in rectal cancer have shown to be adversely
affected by preoperative hypoalbuminaemia. Therefore
the evidence is accumulating to suggest a survival effect
of the SIR in rectal cancer which can be predicted with
easily accessed parameters such as albumin and white
cell count. Furthermore, augmentation of serum albumin
in the peri-operative period with albumin infusions has
failed to demonstrate a significant benefit [23,24]. Serum
albumin may be an indicator of a complex process in-
volving tumour induced and pro-inflammatory factors
that affect survival rather than a previously thought
marker of nutritional status alone in these patients.
Conclusion
Preoperative hypoalbuminaemia is a significant inde-
pendent risk factor for poor overall and disease specific
survival in rectal cancer. Given the available evidence,
SIR seems to have a positive influence on the postopera-
tive outcome in rectal cancer patients. There are mul-
tiple markers which could be used either alone or in
combination as indicators of the SIR. Albumin can be
used as a cost effective and a sensitive marker to predict
survival in rectal cancer compared to other available in-
flammatory markers.
Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
PCC was involves with conception and design, acquisition of data, analysis and
interpretation of data, drafting the article and final approval of the version to be
published. DSE was involved in conception and design, analysis and
interpretation of data, revising the article critically for important intellectual
content, and final approval of the version to be published. SK made a
substantial contribution to conception and design, acquisition of data, revising
the article critically for important intellectual content and final approval of the
version to be published. KID was involved in conception and design, analysis
Chandrasinghe et al. BMC Clinical Pathology 2013, 13:12 Page 5 of 5
http://www.biomedcentral.com/1472-6890/13/12and interpretation of data, drafting the article and revising it critically for
important intellectual content. He was also involved in the final approval of the
version to be published. All authors read and approved the final manuscript.
Received: 26 September 2012 Accepted: 11 April 2013
Published: 16 April 2013
References
1. Bistrian BR, Blackburn GL, Hallowell E, Heddle R: Protein status of general
surgical patients. JAMA 1974, 230:858–860.
2. Berstein LH, Leukhardt-Fairfield CJ, Pleban W, Rudolph R: Usefulness of data
on albumin and prealbumin concentrations in determining effectiveness
of nutritional support. Clin Chem 1989, 35:271–274.
3. Anderson CF, Wochos DN: The utility of serum albumin values in the
nutritional assessment of hospitalized patients. Mayo Clin Proc 1982,
57(3):181–184.
4. Gehring N, Imoberdorf R, Wegmann M, Rühlin M, Ballmer PE: Serum
albumin-a qualified parameter to determine the nutritional status? Swiss
Mel Wkly 2006, 136(41–42):664–669.
5. Fuhrman M, Charney P, Mueller CM: Hepatic proteins and nutrition
assessment. J Am Diet Assoc 2004, 104:1258–1264.
6. Gupta D, Lis CG: Pretreatment serum albumin as a predictor of cancer
survival: a systematic review of the epidemiological literature. Nutr J
2010, 9:69.
7. Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Miki K, Kobayashi K,
Morita K: Elevated C-reactive protein and hypoalbuminemia measured
before resection of colorectal liver metastases predict postoperative
survival. Dig Surg 2010, 27(4):285–290.
8. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K: Inflammation-based
prognostic score is a novel predictor of postoperative outcome in
patients with colorectal cancer. Ann Surg 2007, 246:1047–1051.
9. Roxburgh CS, McMillan DC: Role of systemic inflammatory response in
predicting survival in patients with primary operable cancer. Future Oncol
2010, 6(1):149–163.
10. Feng C, Yao RQ, Huang FZ, Nie WP, Liu XY: Risk factors for anastomotic
leakage after anterior resection for rectal cancer. Nan Fang Yi Ke Da Xue
Xue Bao 2011, 31(5):908–910.
11. Lohsiriwat V, Chinswangwatanakul V, Lohsiriwat S, Akaraviputh T, Boonnuch
W, Methasade A, Lohsiriwat D: Hypoalbuminemia is a predictor of delayed
postoperative bowel function and poor surgical outcomes in right-sided
colon cancer patients. Asia Pac J Clin Nutr 2007, 16:213–217.
12. Lai CC, You JF, Yeh CY, Chen JS, Tang R, Wang JY, Chin CC: Low
preoperative serum albumin in colon cancer: a risk factor for poor
outcome. Int J Colorectal Dis 2011, 26(4):473–481.
13. Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V,
Akaraviputh T, Lert-akayamanee N: Pre-operative hypoalbuminemia is a
major risk factor for postoperative complications following rectal cancer
surgery. World J Gastroenterol 2008, 14(8):1248–1251.
14. Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC:
Systemic inflammatory response is a predictor of outcome in patients
undergoing preoperative chemoradiation for locally advanced rectal
cancer. Colorectal Dis 2012, 14(10):e701–e707.
15. Wijenayake W, Perera M, Balawardena J, Deen R, Wijesuriya SR, Kumarage SK,
Deen KI: Proximal and distal rectal cancers differ in curative resectability
and local recurrence. World J Gastrointest Surg 2011, 3(8):113–118.
16. Heys SD, Walker LG, Deehan DJ, Eremin OE: Serum albumin: a prognostic
indicator in patients with colorectal cancer. J R Coll Surg Edinb 1998,
43(3):163–168.
17. Aamodt R, Bondi J, Andersen SN, Bukholm G, Bukholm IRK: Expression of
nuclear beta catenin in rectal versus colonic cancers. Open Clin Cancer J.
2008, 2:13–17.
18. Bautista CV, Felis CP, Espinet JM, García JB, Salas JV: Telomerase activity is a
prognostic factor for recurrence and survival in rectal cancer. Dis Colon
Rectum 2007, 50(5):611–620.
19. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ: Prognostic scoring
in colorectal cancer liver metastases: development and validation. Arc
Surg 2005, 140(2):183–189.
20. Neal CP, Mann CD, Sutton CD, Garcea G, Ong SL, Steward WP, Dennison AR,
Berry DP: Evaluation of the prognostic value of systemic inflammation
and socioeconomic deprivation in patients with resectable colorectal
liver metastases. Eur J Cancer 2009, 45(1):56–64.21. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS: Evaluation of an
inflammation-based prognostic score (GPS) in patients undergoing
resection for colon and rectal cancer. Int J Colorectal Dis 2007, 22(8):881–886.
22. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS,
Foulis AK, Horgan PG, McMillan DC: A comparison of inflammation-based
prognostic scores in patients with cancer. A Glasgow inflammation
outcome study. Eur J Cancer 2011, 47(17):2633–2641.
23. Rubin H, Carlson S, DeMeo M, Ganger D, Craig RM: Randomized, double-
blind study of intravenous human albumin in hypoalbuminemic patients
receiving total parenteral nutrition. Crit Care Med 1997, 25:249–252.
24. Woods MS, Kelley H: Oncotic pressure, albumin and ileus: the effect of
albumin replacement on postoperative ileus. Am Surg 1993, 59:758–763.
doi:10.1186/1472-6890-13-12
Cite this article as: Chandrasinghe et al.: Pre-operative
hypoalbuminaemia predicts poor overall survival in rectal cancer: a
retrospective cohort analysis. BMC Clinical Pathology 2013 13:12.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
